Carasent (tidligere Apptix)

TekBot · august 25, 2023, 6:41pm

Carasent: Mandatory notification of trade

TekBot · september 6, 2023, 12:55pm

Carasent: Mandatory notification of trade

TekBot · september 21, 2023, 6:21pm

Carasent: Invitation to Capital Markets Day and information regarding distribution to shareholders

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. PLEASE SEE IMPORTANT NOTICE AT THE END OF THIS COMMUNICATION

Carasent ASA (“Carasent” or the “Company) is pleased to invite investors and other interested parties to a Capital Markets Day on Tuesday, 7 November 2023 at 14:00-16:00 CET. The event will be held at Carnegie, Regeringsgatan 56, 111 56 Stockholm, and there will be a live webcast for those not attending in person. More information will be made available before the Capital Markets Day.
…

Vis børsmeldingen

Location: Regeringsgatan 56, 111 56 Stockholm
Date & Time: 7 November 2023, 14:00-16:00

The Board of Directors (the “Board”) of Carasent strongly believes that the Company’s shares are trading at a substantial discount to fair value. Consequently, following a review of the Company’s capital structure, the Board has decided to reduce the Company’s significant net cash position by returning NOK 250 million to shareholders (the “Distribution”). The Board’s view is that following this reduction in net cash position the Company still has a strong balance sheet allowing for an expansive agenda which will be discussed in detail at the Capital Markets Day.

The Distribution will be effected by way of a share buyback by utilizing the authorization as granted by the 2023 annual general meeting (AGM) to repurchase up to 7,962,052 shares in the Company (just below 10% of the current outstanding shares in the Company) (the “Offering”), and an additional cash distribution. The additional cash distribution is conditional upon an extraordinary general meeting approval.

The share buyback is expected to commence Monday 25 September, and will be carried out by means of a book building process where shareholders wanting to sell shares will have a few days to submit the number of shares they are willing to sell and at what price. The Board will determine the number of shares to purchase, final pricing and allocation. The Board thereafter plans to call for an extraordinary general meeting where it will be proposed to make a distribution in equal amounts per share, which will be made by way of a reduction of paid-in capital. The aggregate amount of such proposed distribution will be equal to the difference between NOK 250 million and the amount spent on the repurchase of shares.

For further details please contact: Svein Martin Bjørnstad, CFO Tel: +47 979 69 493, or Daniel Öhman, CEO Tel: +46 70-855 37 07

The information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. The Offer and the distribution of this announcement and other information in connection with the offer may be restricted by law in certain jurisdictions. The Company does not assume any responsibility in the event there is a violation by any person of such restrictions. Persons into whose possession this announcement or relevant information should come are required to inform themselves about and to observe any such restrictions. The offer is not being made directly or indirectly in, or by use of the mails of, or by any means or instrumentality of interstate or foreign commerce of, or any facilities of a national securities exchange of, the United States of America, its territories and possessions, any State of the United States and the District of Columbia (the “United States”). This includes, but is not limited to, facsimile transmission, internet delivery, e-mail and telephones. Copies of this release and any related documents are not being, and must not be, mailed, e-mailed or otherwise distributed or sent in or into the United States and so doing may invalidate any purported acceptance.

Kilde

TekBot · september 25, 2023, 6:00am

Carasent ASA - Offer to shareholders to sell shares to the company

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE
UNLAWFUL. PLEASE SEE IMPORTANT NOTICE AT THE END OF THIS COMMUNICATION
…

Vis børsmeldingen

Carasent ASA (“Carasent” or the "Company) refers to the stock exchange release
22 September 2023 in respect of the Distribution (as defined therein) of NOK
250 million to its shareholders by way of a combination of a share buy-back
and distribution on shares. The Company has decided to initiate a share
buy-back of up to 7,962,052 shares, pursuant to the authorization given by the
Company’s Annual General Meeting on 3 May 2023 (the “Offer”). The shares
purchased through the share buyback may be used for prospective reductions of
the share capital.

The Offer will be carried out as a reversed book-building process which starts
on 25 September 2023 at 09:00 CEST and will close no later than 28 September
2023 at 16:30 CEST (the “Application Period”). The Company reserves the right
to close or extend the Application Period at its own discretion without
further notice. Pricing and allocation are expected on or about 29 September
2023, the trade date is expected to be on or about 29 September 2023 with
settlement date expected on or about 3 October 2023. If the Application Period
is extended the dates referred to herein may be amended accordingly.

The Company has mandated DNB Markets, a part of DNB Bank ASA ("DNB Markets) as
sole bookrunner for the Offer. DNB Markets will receive and accumulate sales
orders from shareholders submitting the acceptance form published with this
release via email demand@dnb.no. Existing customers of DNB Markets may also
provide their order / respective volume and price targets to DNB Markets by
telephone +47 24 16 90 20. Sales orders received and terms offered by the
relevant shareholders are irrevocable and cannot be changed.

The final purchase price will be identical for all selling shareholders. The
Company will in the event of receiving orders above 7,962,052 shares depending
on the prices and volumes requested by shareholders, allocate shares at its
discretion in accordance with the best interest of the Company, with the equal
treatment of shareholders as the primary objective. The Company reserves the
right to, at its own discretion to buy back fewer shares or no shares at all,
to terminate the Offer or make any amendments regarding the volume or other
terms of the contemplated Offer. The Company may further, at its sole
discretion terminate, withdraw or extend the Offer at any time until notices
of allocations have been sent.

For further details please contact: Svein Martin Bjørnstad, CFO Tel: +47 979
69 493, or Daniel Öhman, CEO Tel: +46 70-855 37 07.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 the Norwegian Securities Trading Act. This stock exchange
announcement was published by Svein Martin Bjørnstad, CFO, on 25 September
2023 at 08:00 CEST.

The Offer and the distribution of this announcement and other information in
connection with the offer may be restricted by law in certain jurisdictions.
The Company does not assume any responsibility in the event there is a
violation by any person of such restrictions. Persons into whose possession
this announcement or relevant information should come are required to inform
themselves about and to observe any such restrictions. The offer is not being
made directly or indirectly in, or by use of the mails of, or by any means or
instrumentality of interstate or foreign commerce of, or any facilities of a
national securities exchange of, the United States of America, its territories
and possessions, any State of the United States and the District of Columbia
(the “United States”). This includes, but is not limited to, facsimile
transmission, internet delivery, e-mail and telephones. Copies of this release
and any related documents are not being, and must not be, mailed, e-mailed or
otherwise distributed or sent in or into the United States and so doing may
invalidate any purported acceptance.

This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication at
2023-09-25 08:00 CEST.

Kilde

TekBot · september 27, 2023, 2:50pm

Carasent ASA - Share buy-back price guidance

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE
UNLAWFUL. PLEASE SEE IMPORTANT NOTICE AT THE END OF THIS COMMUNICATION
…

Vis børsmeldingen

Reference is made to the notice issued on 25 September 2023, where Carasent
ASA (the “Company”) launched an offer to buy back up to 7,962,052 shares in
the Company (the “Offering”).

Based on acceptances from shareholders, the Company intends to acquire shares
in the Offering at a price expected around NOK 16 per share.

The Offering is carried out by means of a reverse book building process, which
ends on 28 September 2023 at 16:30 (CEST). The Company reserves the right to
close or extend the Application Period at its own discretion without further
notice. The Company has mandated DNB Markets as sole bookrunner. Shareholders
wanting to sell shares in the Offering are required to complete and send the
acceptance form to DNB Markets at demand@dnb.no before 28 September 2023 at
16:30 (CEST). Existing customers of DNB Markets can contact DNB Markets at +47
24 16 90 20 with their respective volume and price targets.

The Company will in the event of receiving orders above 7,962,052 shares
depending on the prices and volumes requested by shareholders, allocate shares
at its discretion in accordance with the best interest of the Company, with
the equal treatment of shareholders as the primary objective. The Company
reserves the right to, at its own discretion to buy back fewer shares or no
shares at all, to terminate the Offer or make any amendments regarding the
volume or other terms of the contemplated Offer. The Company may further, at
its sole discretion terminate, withdraw or extend the Offer at any time until
notices of allocations have been sent.

For further details please contact: Svein Martin Bjørnstad, CFO Tel: +47 979
69 493, or Daniel Öhman, CEO Tel: +46 70-855 37 07

IMPORTANT NOTICE

The Offering will be carried out in accordance with applicable laws and
regulations and information pertaining to the Offering will be disclosed by
way of stock exchange notices.

The information contained herein about the Offering is considered to be inside
information pursuant to the EU Market Abuse Regulation (MAR) and is subject to
the disclosure requirements pursuant to MAR article 17 and section 5-12 of the
Norwegian Securities Trading Act. This stock exchange release was published by
Svein Martin Bjørnstad on 27 September 2023 at 16:50 (CEST).

Shareholders considering to tender their shares in the Offering are advised to
consult with their own tax advisers with respect to the tax position in their
country of residence or other jurisdictions to which they may have a tax
liability as a result of a sale of shares in the Offering.

The Offer and the distribution of this announcement and other information in
connection with the offer may be restricted by law in certain jurisdictions.
The Company does not assume any responsibility in the event there is a
violation by any person of such restrictions. Persons into whose possession
this announcement or relevant information should come are required to inform
themselves about and to observe any such restrictions. The offer is not being
made directly or indirectly in, or by use of the mails of, or by any means or
instrumentality of interstate or foreign commerce of, or any facilities of a
national securities exchange of, the United States of America, its territories
and possessions, any State of the United States and the District of Columbia
(the “United States”). This includes, but is not limited to, facsimile
transmission, internet delivery, e-mail and telephones. Copies of this release
and any related documents are not being, and must not be, mailed, e-mailed or
otherwise distributed or sent in or into the United States and so doing may
invalidate any purported acceptance.

This information is information that Carasent is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was submitted for
publication, through the agency of the contact persons set out above, at
2023-09-27 16:50 CEST.

Kilde

TekBot · september 28, 2023, 7:00pm

Carasent ASA: Share buy back result

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE
UNLAWFUL. PLEASE SEE IMPORTANT NOTICE AT THE END OF THIS COMMUNICATION
…

Vis børsmeldingen

Reference is made to the notice issued on 25 September 2023, where Carasent
ASA (the “Company”) launched an offer to all shareholders to purchase up to
7,962,052 shares in the Company through a reverse book building process (the
“Offering”). The application period expired at 16:30 hours (CEST) on 28
September 2023.

Following the end of the application period, the Company has resolved to buy
7,295,747 shares at price per share of NOK 16.00. As such, the total share
repurchase will amount to 116,731,952 NOK.

Allocation notifications will be sent to shareholders having tendered shares
in the Offering on or about 29 September 2023. The trade date is expected to
be on or about 29 September 2023 and the settlement date is expected to be on
or about 3 October 2023. The settlement will be conducted on a normal
delivery-versus-payment basis (DVP) or through the VPS system.

Following settlement of the Offering, Carasent ASA will own 7,295,747 shares.

The company expects to call for an EGM to be held 14 November to seek approval
for an extraordinary distribution of NOK 133 million bringing the total
distribution, across the share repurchase and the extraordinary cash
distribution, up to NOK 250 million, in line with what was communicated in the
notice issued on 21 September 2023.

Carasent will host a capital markets day in Stockholm, Regeringsgatan 56, 111
56, at 7 November 14:00 - 16:00.

For further details please contact: Svein Martin Bjørnstad, CFO Tel: +47 979
69 493, or Daniel Öhman, CEO Tel: +46 70-855 37 07

The information contained herein about the Offering is considered to be inside
information pursuant to the EU Market Abuse Regulation (MAR) and is subject to
the disclosure requirements pursuant to MAR article 17 and section 5-12 of the
Norwegian Securities Trading Act. This stock exchange release was published by
Svein Martin Bjørnstad on 28 September 2023 at 21:00 (CEST).

IMPORTANT NOTICE

The Offer and the distribution of this announcement and other information in
connection with the offer may be restricted by law in certain jurisdictions.
The Company does not assume any responsibility in the event there is a
violation by any person of such restrictions. Persons into whose possession
this announcement or relevant information should come are required to inform
themselves about and to observe any such restrictions. The offer is not being
made directly or indirectly in, or by use of the mails of, or by any means or
instrumentality of interstate or foreign commerce of, or any facilities of a
national securities exchange of, the United States of America, its territories
and possessions, any State of the United States and the District of Columbia
(the “United States”). This includes, but is not limited to, facsimile
transmission, internet delivery, e-mail and telephones. Copies of this release
and any related documents are not being, and must not be, mailed, e-mailed or
otherwise distributed or sent in or into the United States and so doing may
invalidate any purported acceptance.

This information is information that Carasent is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was submitted for
publication, through the agency of the contact persons set out above, at
2023-09-28 21:00 CEST.

Kilde

TekBot · september 29, 2023, 9:41am

Major shareholder disclosure

TekBot · oktober 1, 2023, 11:59am

Carasent ASA - Disclosure of large shareholding

13,319,838 shares in Carasent ASA were Friday, 29 September 2023 resolved to
be transferred from Aeternum Capital AS to ACapital CARA HoldCo AS by way of a
capital contribution in kind. Aeternum Capital AS is managed by Aeternum
…

Vis børsmeldingen

Management AS. ACapital CARA HoldCo AS is a 100% owned subsidiary of Aeternum
Capital AS. Consequently, no change of beneficial ownership to the shares in
Carasent ASA occurs as a result of the transfer, only the direct holder of the
shares.

Following the transfer, ACapital CARA HoldCo AS holds 13,319,838 shares in
Carasent ASA, equal to approx. 16.73% of the votes and share capital. Aeternum
Capital AS holds no shares in Carasent ASA following the transfer. No other
rights to shares in Carasent ASA are held by any of the above mentioned
entities.

This information is subject to the disclosure requirements pursuant to
Sections 4-2, cf. 5-12 of the Norwegian Securities Trading Act.

Kilde

TekBot · oktober 16, 2023, 6:23pm

Carasent ASA registration link Capital Markets Day

Reference is made to the notice issued on 21 September 2023, where Carasent
ASA announced an invitation to investors and other interested parties to a
Capital Markets Day.
…

Vis børsmeldingen

The event will be held at Carnegie Head office in Stockholm on Tuesday, 7
November 2023 at 14:00-16:00 CET, and there will be a live webcast for those
not attending in person.

Register for the event below

We hope you can attend our Capital Markets Day in Stockholm. Places are
limited and will be reserved on a first-come, first-served basis.

If you wish to participate physically please register on the link below.

Link for registration: Carasent, Capital Markets Day, 2023 | Financial
Hearings (Carasent, Capital Markets Day, 2023 | Financial Hearings). Please register no later
than 5 November 2023.

If you wish to participate via webcast please use the link below.

Link for webcast: https://ir.financialhearings.com/carasent-cmd-2023

For further details please contact:

Daniel Öhman, CEO Tel: +46 70-855 37 07, or

Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

Kilde

TekBot · oktober 21, 2023, 12:01pm

Carasent ASA - Calling notice for extraordinary general meeting

TekBot · oktober 23, 2023, 9:46am

Carasent ASA - Key information relating to proposed distribution

Reference is made to the notice issued on 21 October 2023, where the Board of
Carasent ASA has proposed a cash distribution on ordinary shares to an
extraordinary general meeting to be held on 14 November 2023.
…

Vis børsmeldingen

Below are key dates for the proposed distribution:

Dividend amount: NOK 1.84 per ordinary share
Currency: NOK (Norwegian kroner)
Date for resolution: 14 November 2023
Last day inclusive: 14 November 2023
Ex-date: 15 November 2023
Record date: 16 November 2023
Payment date: 23 November 2023

For further details please contact:

Petri Nemi, Chairman of the Board Tel: +358 40 051 1493, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication at
2023-10-23 11:45 CEST.

Kilde

TekBot · oktober 23, 2023, 10:40am

Carasent ASA - Invitation to presentation of Q3 2023 results

TekBot · oktober 26, 2023, 5:01am

Carasent ASA - Q3 2023 financial results and presentation

TekBot · november 7, 2023, 7:01am

Carasent ASA announcement of long-term financial targets

Carasent ASA (“Carasent”, or the “Company”) has today updated its financial
targets for long-term revenue growth and profitability. The updated targets
will be presented in detail today at the Capital Markets Day (“CMD”).
…

Vis børsmeldingen

Carasent is targeting average annual organic revenue growth above 15% during
2024 to 2026. The Company also targets improved profitability, with reported
EBITDA margin reaching 25% by 2026 and a reported EBITDAC (EBITDA – capex)
margin to reach 15% by 2026. The financial targets are intended for a
long-term perspective, and there will be variations between quarters.

“Carasent is entering an exciting new phase building upon our leading market
positions and unique offering. We are currently investing heavily into product
development that will drive long-term revenue growth. We aim to grow our
revenues considerably faster than our costs during the next few years, leading
to increasing margins.” says Daniel Öhman, CEO of Carasent.

Long-term financial targets

Average annual organic revenue growth above 15% during 2024-2026

EBITDA margin to reach 25% by 2026

EBITDAC margin to reach 15% by 2026

We are executing our strategy to reach targets with our current company
structure. Potential acquisitions are not included

The CMD will provide investors and analysts with an in-depth overview of
Carasent’s structure today, as well as its growth journey, including potential
for acquisitions and route for international expansion. The CMD will also
provide insights into the Company’s strategy and how it plans to achieve its
financial targets.

The CMD will be held at Carnegie Head office in Stockholm at 14:00. A live
webcast of the event will also be available on the company’s website. The
event will also include a Q&A session with management.

Link for webcast: https://ir.financialhearings.com/carasent-cmd-2023

For further details please contact:

Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

This information is information that Carasent is obliged to make public
pursuant to the EU Market Abuse Regulation. The information was submitted for
publication, through the agency of the contact persons set out above, at
2023-11-07 08:00 CET.

Kilde

TekBot · november 7, 2023, 9:02pm

Carasent ASA - Capital Markets Day presentation

TekBot · november 9, 2023, 12:26pm

CARA: Board member byuing shares

TekBot · november 14, 2023, 9:11am

Carasent ASA - Minutes from the Extraordinary General Meeting

TekBot · november 15, 2023, 6:01am

Carasent ASA - Ex dividend today

TekBot · november 20, 2023, 2:30pm

Carasent ASA - primary insider trading

TekBot · november 21, 2023, 6:47pm

Carasent group signs contract to supply Metodika EPM to Volvat Medisinske Senter AS

Volvat Medisinske Senter AS and Metodika AB have entered into an agreement to
implement the EHR system Metodika EPM at Volvat’s hospitals and clinics in
Norway. The annual revenue from the contract is estimated to 7-9 MNOK, where
…

Vis børsmeldingen

the majority is recurring revenue (“ARR”).

Volvat Medisinske Senter AS has performed an extensive procurement process
with the objective to find the most suitable EHR for a complex business such
as Volvat’s, one of the largest private healthcare providers in Norway with 27
centres across the country. This procurement process has now concluded in a
decision to implement Metodika EPM across Volvat’s business. In total 5
different EHR systems currently used by Volvat will be replaced by Metodika
EPM.

The yearly value of the contract after the implementation process is estimated
to 7-9 MNOK where the majority is ARR. The remaining expected revenue is
related to implementation, adaptations and consultancy work. The work on
implementation will start immediately and it is expected that the first
centres will start using Metodika EPM by the second half of 2024. The ARR will
be generated once the system is in production, until then implementation work
is expected to have a slight negative effect on Metodika’s margins.

Carasent CEO Daniel Öhman comments:

The agreement with Volvat strengthens Metodika’s position as a leading
supplier to private hospitals and clinics in the Nordics, with a breadth of
functionality in the system that is unmatched in the market. Carasent sees
good potential to continue to expand Metodika’s presence within this segment.

Volvat CEO Per Helge Fagermoen comments:

We are pleased to sign an agreement with Metodika after a long and thorough
procurement process. The agreement aims to achieve the “one Volvat” strategy,
where we look at implementing our vision and strategy across the group. We
look forward to work with Metodika in this process.

About Metodika:

Metodika’s EPM system is used by more than 100 private hospitals and clinics
across 10 countries in northern Europe. The system is designed for
administrative efficiency and clinical quality and can be adapted to each
clients and markets unique needs. It covers all aspects of the patient journey
with the caregiver.

About Volvat:

Volvat is Norway’s first private hospital and has over 30 years of experience
in offering patients various health services and reducing health queues. The
Volvat Group is one of the country’s leading private health trusts and is
present for patients all over the country with 27 centres located across
Norway.

The centres have a wide range of medical services ranging from
health-promoting and preventive work to treatment and rehabilitation.

Volvat is owned by Ramsay Health, which also operates large hospitals and
medical centres in Norway, Sweden, Denmark, Germany, France, the United
Kingdom, Italy, Malaysia, Singapore, Indonesia and Australia.

For further details please contact:

Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

Kilde